Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Viatris Inc (VTRS) vs Wells Fargo & Co (WFC) Price & Performance

Viatris IncTrade
Wells Fargo & CoTrade

Price performance (Past 24H)

Key statistics

Viatris Inc vs Wells Fargo & Co — how do they compare? Viatris Inc trades at $16.28 (market cap $18.69B), while Wells Fargo & Co trades at $87.3 (market cap $264.66B). The key difference: Wells Fargo & Co is far larger — about 14.2× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.95%). Which is the better fit depends on your goals.

VTRSWFC
Market Cap
$18.69B$264.66B
Sector
HealthFinancials
52-Week High
$17.86$96.40
52-Week Low
$9.49$73.42
Enterprise Value
$30.80B
Dividend Yield
2.95%2.29%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS

About Wells Fargo & Co

Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.

Read more on WFC